XTAE
ERKA
Market cap5mUSD
Oct 30, Last price
39.90ILS
1D
0.00%
1Q
-19.23%
IPO
-97.66%
Name
Erika B-Cure Laser Ltd
Chart & performance
P/E
—
P/S
0.48
EPS
—
Vol. 1Y
71.23%
Shs. 5Y
0.12%
Rev. 5Y
-5.67%
Div Yld LY
—
Div Yld TTM
—
Revenues
38m
+27.03%
Net income
-9m
L-50.73%
CFO
-4m
L-52.91%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Erika Carmel-Tech Ltd. is an international company, which develops markets and distributes the B-Cure Laser products. It is designed to treat pain, orthopedic disorders, wounds and inflammations, for daily domestic use in the comfort of home; these are a series of revolutionary lightweight and portable devices. The company was founded on October 9, 2007 and is headquartered in Haifa, Israel.
Key people
Aviram Cohen
Chief Financial Officer · since 2019
Itay Avni
Regional Business Development Manager and Manager UK · since 2018
Maor Herd
Digital Department Manager · since 2017
Alon Heth
Business Development Manager for Vet and Dental Products · since 2021
Guy Simon
Manager of a Sales Center in Israel · since 2014
Yoav Barak
Director · since 2021
Moti Navon
Chief Executive Officer, Director · since 2021
Michael Schlosser
Chairman of the Board · since 2018
Zipporah Schlosser
Vice President, Director · since 2017
Valuation
Title ILS in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | |
| Income | |||||||
Revenues | |||||||
Cost of revenue | |||||||
Unusual Expense (Income) | |||||||
NOPBT | |||||||
NOPBT Margin | |||||||
Operating Taxes | |||||||
Tax Rate | |||||||
NOPAT | |||||||
Net income | |||||||
Dividends | |||||||
Dividend yield | |||||||
Proceeds from repurchase of equity | |||||||
BB yield | |||||||
| Debt | |||||||
Debt current | |||||||
Long-term debt | |||||||
Deferred revenue | |||||||
Other long-term liabilities | |||||||
Net debt | |||||||
| Cash flow | |||||||
Cash from operating activities | |||||||
CAPEX | |||||||
Cash from investing activities | |||||||
Cash from financing activities | |||||||
FCF | |||||||
| Balance | |||||||
Cash | |||||||
Long term investments | |||||||
Excess cash | |||||||
Stockholders' equity | |||||||
Invested Capital | |||||||
ROIC | |||||||
ROCE | |||||||
| EV | |||||||
Common stock shares outstanding | |||||||
Price | |||||||
Market cap | |||||||
EV | |||||||
EBITDA | |||||||
EV/EBITDA | |||||||
Interest | |||||||
Interest/NOPBT | |||||||